CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 4 Planned sale Chief Financial Officer sold 2,145 shares at $18.46 ($39,597)
- 8-K Event Results of operations
- 4 Planned sale Chief Scientific Officer sold 42,788 shares at an average $18.68 ($799,105)
- 4 Planned sale CEO and Chairman sold 124,998 shares at $18.44 ($2,304,963)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief People Officer sold 79,590 shares at $17.73 ($1,411,131)
- 4 Planned sale Chief Financial Officer sold 4,290 shares at $18.00 ($77,220)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale Chief Scientific Officer sold 10,000 shares at $16.44 ($164,400)
- 4/A Planned sale Chief People Officer sold 4,394 shares at $17.50 ($76,895)
- 4 Planned sale CEO and Chairman sold 124,998 shares at $15.59 ($1,948,719)
- 4 Planned sale Chief People Officer sold 3,125 shares at $16.08 ($50,250)
- 144 Insider Sale of Securities
Page 8 of 42 · 836 filings